tiprankstipranks
Trending News
More News >

China Health Technology Group Appoints New CEO for Subsidiary

Story Highlights
China Health Technology Group Appoints New CEO for Subsidiary

Confident Investing Starts Here:

The latest announcement is out from China Bozza Development Holdings Limited ( (HK:1069) ).

China Health Technology Group Holding Company Limited has announced the appointment of Mr. Li Zhiliang as the CEO of its subsidiary, Genmao (Shenzhen) Biotechnology Co., Ltd. Mr. Li brings over 22 years of experience in the acer truncatum industry and has been involved in national projects and standards related to acer truncatum. His appointment is expected to enhance the company’s technological capabilities and brand influence, contributing to long-term shareholder value.

More about China Bozza Development Holdings Limited

China Health Technology Group Holding Company Limited operates in the biotechnology sector, with a focus on the development of the entire industrial chain of acer truncatum, particularly in the functional food and oil market.

YTD Price Performance: -2.50%

Average Trading Volume: 1,760,747

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$34.37M

Find detailed analytics on 1069 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App